Related references
Note: Only part of the references are listed.Mesothelin Enhances Tumor Vascularity in Newly Forming Pancreatic Peritoneal Metastases
Leela Rani Avula et al.
MOLECULAR CANCER RESEARCH (2020)
Proteolytic ectodomain shedding of membrane proteins in mammals-hardware, concepts, and recent developments
Stefan F. Lichtenthaler et al.
EMBO JOURNAL (2018)
Secretase inhibitors for the treatment of Alzheimer's disease: Long road ahead
Devendra Kumar et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Overcoming barriers of car T-cell therapy in patients with mesothelin-expressing cancers
Mark H. O'Hara et al.
IMMUNOTHERAPY (2017)
BACE1 Inhibitor Lanabecestat (AZD3293) in a Phase 1 Study of Healthy Japanese Subjects: Pharmacokinetics and Effects on Plasma and Cerebrospinal Fluid A Peptides
Kei Sakamoto et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Amatuximab and novel agents targeting mesothelin for solid tumors
Paolo Baldo et al.
ONCOTARGETS AND THERAPY (2017)
Mesothelin-Targeted CARs: Driving T Cells to Solid Tumors
Aurore Morello et al.
CANCER DISCOVERY (2016)
Mesothelin Immunotherapy for Cancer: Ready for Prime Time?
Raffit Hassan et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Reduced Shedding of Surface Mesothelin Improves Efficacy of Mesothelin-Targeting Recombinant Immunotoxins
Prince Awuah et al.
MOLECULAR CANCER THERAPEUTICS (2016)
In Vitro and In Vivo Activity of the Low-Immunogenic Antimesothelin Immunotoxin RG7787 in Pancreatic Cancer
Kevin Hollevoet et al.
MOLECULAR CANCER THERAPEUTICS (2014)
The Insulin Receptor Negatively Regulates the Action of Pseudomonas Toxin-Based Immunotoxins and Native Pseudomonas Toxin
Xiu Fen Liu et al.
CANCER RESEARCH (2013)
Ectodomain shedding and ADAMs in development
Silvio Weber et al.
DEVELOPMENT (2012)
Cytotoxic Activity of Immunotoxin SS1P Is Modulated by TACE-Dependent Mesothelin Shedding
Yujian Zhang et al.
CANCER RESEARCH (2011)
The ADAM metalloproteinases
Dylan R. Edwards et al.
MOLECULAR ASPECTS OF MEDICINE (2008)
Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors
Jennifer A. A. Gubbels et al.
MOLECULAR CANCER (2006)
Mesothelin variant 1 is released from tumor cells as a diagnostic marker
Ingegerd Hellstrom et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancer
R Hassan et al.
CLINICAL CANCER RESEARCH (2006)
Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion
A Rump et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Mice deficient in BACE1, the Alzheimer's β-secretase, have normal phenotype and abolished β-amyloid generation
Y Luo et al.
NATURE NEUROSCIENCE (2001)
BACE2, a β-secretase homolog, cleaves at the β site and within the amyloid-β region of the amyloid-β precursor protein
M Farzan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)